BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 22276606)

  • 1. Patients with thymomas have an increased risk of developing additional malignancies: lack of immunological surveillance?
    Granato F; Ambrosio MR; Spina D; Lazzi S; Rocca BJ; Voltolini L; Bongiolatti S; Luzzi L; Gotti G; Leoncini L; Tosi P
    Histopathology; 2012 Feb; 60(3):437-42. PubMed ID: 22276606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression of CD20 in thymomas and its clinical implication].
    Du J; Zhou XJ; Yin HL; Lu ZF; Zhou HB
    Zhonghua Bing Li Xue Za Zhi; 2010 Sep; 39(9):611-4. PubMed ID: 21092589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WHO histologic classification is a prognostic indicator in thymoma.
    Kondo K; Yoshizawa K; Tsuyuguchi M; Kimura S; Sumitomo M; Morita J; Miyoshi T; Sakiyama S; Mukai K; Monden Y
    Ann Thorac Surg; 2004 Apr; 77(4):1183-8. PubMed ID: 15063231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of podoplanin in thymoma: its correlation with tumor invasion, nodal metastasis, and poor clinical outcome.
    Tateyama H; Sugiura H; Yamatani C; Yano M
    Hum Pathol; 2011 Apr; 42(4):533-40. PubMed ID: 21237498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of neurotrophin receptors in surgically resected thymic epithelial tumors.
    Kim DJ; Yang WI; Kim SH; Park IK; Chung KY
    Eur J Cardiothorac Surg; 2005 Oct; 28(4):611-6. PubMed ID: 16125946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corpuscular thymoma: entity or variant of organotypical thymomas WHO B2/B3?
    Laeng RH; Eimoto T; Kuo TT; Zettl A; Marx A; Moschopulos M; Tateyama H; Shimokawa K
    Pathol Res Pract; 2006; 202(10):697-704. PubMed ID: 16887284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glia maturation factor-beta is produced by thymoma and may promote intratumoral T-cell differentiation.
    Yamazaki H; Tateyama H; Asai K; Fukai I; Fujii Y; Tada T; Eimoto T
    Histopathology; 2005 Sep; 47(3):292-302. PubMed ID: 16115230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. World Health Organization histologic classification: an independent prognostic factor in resected thymomas.
    Rena O; Papalia E; Maggi G; Oliaro A; Ruffini E; Filosso P; Mancuso M; Novero D; Casadio C
    Lung Cancer; 2005 Oct; 50(1):59-66. PubMed ID: 16009453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thymic epithelial tumors: comparison of CT and MR imaging findings of low-risk thymomas, high-risk thymomas, and thymic carcinomas.
    Sadohara J; Fujimoto K; Müller NL; Kato S; Takamori S; Ohkuma K; Terasaki H; Hayabuchi N
    Eur J Radiol; 2006 Oct; 60(1):70-9. PubMed ID: 16766154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical usefulness of the WHO histological classification of thymoma.
    Sonobe S; Miyamoto H; Izumi H; Nobukawa B; Futagawa T; Yamazaki A; Oh T; Uekusa T; Abe H; Suda K
    Ann Thorac Cardiovasc Surg; 2005 Dec; 11(6):367-73. PubMed ID: 16401984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathological aspects of malignant and benign thymic disorders.
    Müller-Hermelink HK; Marx A
    Ann Med; 1999 Oct; 31 Suppl 2():5-14. PubMed ID: 10574149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal thymocyte development and generation of autoreactive T cells in mixed and cortical thymomas.
    Nenninger R; Schultz A; Hoffacker V; Helmreich M; Wilisch A; Vandekerckhove B; Hünig T; Schalke B; Schneider C; Tzartos S; Kalbacher H; Müller-Hermelink HK; Marx A
    Lab Invest; 1998 Jun; 78(6):743-53. PubMed ID: 9645765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PD-L1, PD-1, CD4, and CD8 expression in neoplastic and nonneoplastic thymus.
    Marchevsky AM; Walts AE
    Hum Pathol; 2017 Feb; 60():16-23. PubMed ID: 27746267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clusters of chromosomal imbalances in thymic epithelial tumours are associated with the WHO classification and the staging system according to Masaoka.
    Penzel R; Hoegel J; Schmitz W; Blaeker H; Morresi-Hauf A; Aulmann S; Hecker E; Mechtersheimer G; Otto HF; Rieker RJ
    Int J Cancer; 2003 Jul; 105(4):494-8. PubMed ID: 12712440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Demonstration of phenotypic abnormalities of thymic epithelium in thymoma including two cases with abundant Langerhans cells.
    Kraus VB; Harden EA; Wittels B; Moore JO; Haynes BF
    Am J Pathol; 1988 Sep; 132(3):552-62. PubMed ID: 3261946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type B thymoma: is prognosis predicted only by World Health Organization classification?
    Kim HK; Choi YS; Kim J; Shim YM; Han J; Kim K
    J Thorac Cardiovasc Surg; 2010 Jun; 139(6):1431-1435.e1. PubMed ID: 20038470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of proteasome subunit β5t in thymic epithelial tumors.
    Yamada Y; Tomaru U; Ishizu A; Kiuchi T; Marukawa K; Matsuno Y; Kasahara M
    Am J Surg Pathol; 2011 Sep; 35(9):1296-304. PubMed ID: 21836487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New WHO histologic classification predicts prognosis of thymic epithelial tumors: a clinicopathologic study of 200 thymoma cases from China.
    Chen G; Marx A; Chen WH; Yong J; Puppe B; Stroebel P; Mueller-Hermelink HK
    Cancer; 2002 Jul; 95(2):420-9. PubMed ID: 12124843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective loss of regulatory T cells in thymomas.
    Ströbel P; Rosenwald A; Beyersdorf N; Kerkau T; Elert O; Murumägi A; Sillanpää N; Peterson P; Hummel V; Rieckmann P; Burek C; Schalke B; Nix W; Kiefer R; Müller-Hermelink HK; Marx A
    Ann Neurol; 2004 Dec; 56(6):901-4. PubMed ID: 15562414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corticomedullary differentiation and maturational arrest in thymomas.
    Ströbel P; Hartmann E; Rosenwald A; Kalla J; Ott G; Friedel G; Schalke B; Kasahara M; Tomaru U; Marx A
    Histopathology; 2014 Mar; 64(4):557-66. PubMed ID: 24236644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.